A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects-Reference-Cited by-同舟云学术

A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects

Published:2000-06 Issue:6 Volume:14 Page:691-699
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Williams ,Blanshard ,Millson ,Sercombe ,Pounder

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2000.00772.x/fullpdf

Reference25 articles.

1. The proton pump inhibitor E3810 binds to the N-terminal half of the α-subunit of gastric H+/K+-ATPase;Morii;Biochem Pharmacol,1995

2. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione;Fujisaki;Biochem Pharmacol,1991

3. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents;Besancon;J Biol Chem,1997

4. Effects of the proton pump inhibitor, E3820, on gastric secretion and gastric duodenal ulcers or erosions in rats;Fujisaki;Drug Invest,1991

5. Rabeprazole effectively inhibits 24-hour H+ activity and nocturnal acid secretion in healthy subjects;Dammann;Gut,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial;Frontiers in Medicine;2021-07-14

2. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study;Cancer Chemotherapy and Pharmacology;2018-12-10

3. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency;Clinical Gastroenterology and Hepatology;2018-06

4. Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions;Clinical Pharmacology in Drug Development;2017-04-21

5. Rabeprazole;Meyler's Side Effects of Drugs;2016